TASE

3 stories about TASE
קולפלנט דיו ביולוגי

Collplant Secures $7.4 million in Private Placement

13.11.17|Lilach Baumer
Over the past three months, the TASE-listed regenerative medicine company submitted several filings regarding investments made by private investors
ראג'יב מאליק נשיא מיילן

Investors Cheer as Mylan Plans to Delist from Israeli Stock Exchange

12.11.17|Uri Tal-Tenne and Dror Reich
Mylan is currently the highest valued company on the TASE at $18.5 billion
מפעל חברת טבע הר חוצבים ירושלים

Teva’s Perfect Storm Sends Tel-Aviv Stock Exchange Down

06.08.17|Calcalist
Teva’s stock price dropped sharply on Thursday and Friday after the company released quarterly revenue and profits that fell short of analysts’ forecasts